1.1 	A bill for an act
1.2 	relating to health insurance; prohibiting health plans from limiting testing for 
1.3 	opioids;amending Minnesota Statutes 2020, section 256B.0625, subdivision 10; 
1.4 	proposing coding for new law in Minnesota Statutes, chapter 62Q.
1.5 	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

1.6 	Section 1. [62Q.472] SCREENING AND TESTING FOR OPIOIDS.
1.7 	(a) A health plan company shall not place a lifetime or annual limit on screenings and 
1.8 	urinalysis testing for opioids for an enrollee in an inpatient or outpatient substance use 
1.9 	disorder treatment program when ordered by a health care provider and performed by an 
1.10 	accredited clinical laboratory. A health plan company is not prohibited from conducting a 
1.11 	medical necessity review when screenings or urinalysis testing for an enrollee exceeds 24 
1.12 	tests in any 12-month period.
1.13 	(b) This section does not apply to managed care plans or county-based purchasing plans 
1.14 	when the plan is providing coverage to public health care program enrollees under chapter 
1.15 	256B or 256L.

1.16 	EFFECTIVE DATE. This section is effective January 1, 2022, and applies to health 
1.17 	plans offered, issued, or renewed on or after that date.

1.18 	Sec. 2. Minnesota Statutes 2020, section 256B.0625, subdivision 10, is amended to read:
1.19 		Subd. 10.Laboratory and x-ray services. (a) Medical assistance covers laboratory and 
1.20 	x-ray services.
1.21 	(b) Medical assistance covers screening and urinalysis tests for opioids without lifetime 
1.22 	or annual limits.

2.1 	EFFECTIVE DATE. This section is effective January 1, 2022.